Please assess the completion status of the following clinical trial:

Trial Title: Effect of C1-esterase Inhibitor on Systemic Inflammation in Trauma Patients With a Femur or Pelvic Fracture

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Multi trauma patients~* Femur or pelvic fracture~* Injury Severity Score (ISS) ≥ 18~* Age 18-80 yrs~Exclusion Criteria:~* Congenital C1-inhibitor deficiency~* Use of immune suppressants~* Pregnancy~* Known hypersensitivity for blood products~* Fixation of femur fracture with external fixation or osteosynthesis

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- C1-esterase inhibitor (Type: ACTIVE_COMPARATOR): C1-esterase inhibitor, 100 U/kg bodyweight
- Saline 0.9% (Type: PLACEBO_COMPARATOR): Saline 0.9%

Based on this trial design, predict the completion outcome and termination type (if applicable).